Pelago Health background photo
Pelago Health profile photo

Pelago Health Careers, Benefits, Review

Pelago is leading online clinic that offers offers personalized treatment for people looking to overcome tobacco, alcohol, and opioid use. The company is committed to giving employers the means to offer on-demand, personalized support to workers.

Website Globe icon https://pelagohealth.com

26 fans
ChangemakerDiversity ChampionFamily Friendly
and 2 other badges...
Pelago Health Glassdoor Company Review
4.4 Glassdoor star iconGlassdoor star iconGlassdoor star iconGlassdoor star icon Glassdoor star icon
Pelago Health DE&I Review
No rating Glassdoor star iconGlassdoor star iconGlassdoor star iconGlassdoor star iconGlassdoor star icon
CEO of Pelago Health
Pelago Health CEO photo
Yusuf Sherwani
Approve of CEO
Pelago Health Employee Reviews
Featured review

Ideas and innovation are valued!

5/1/2024 -
Recommends
Positive outlook
Approves of CEO

Pros

Thoughtful, caring leaders Critical mission There are a lot of opportunities to add value

Cons

Pelago is still a start up, which means that everyone works very hard but it is worth it
About

Pelago (formerly Quit Genius) is the world’s leading virtual clinic for substance use management. We are transforming substance use support—from prevention to treatment—delivering education, management skills, and opportunities for positive change to members struggling with substance use, most commonly tobacco, alcohol, or opioids. Our solution gives employers the means to offer on-demand, personalized support to workers seeking to live healthier lives. Pelago’s cognitive behavioral therapy (CBT) and medication-assisted treatment (MAT) programs deliver convenient, accessible, and effective support that seamlessly integrates with health plans, pharmacy benefit managers, and wellness platforms. To date, Pelago has helped more than 750,000 members manage their substance use and improve their lives. Visit www.pelagohealth.com for more information.

Funding
Total Funding
AMOUNT $136.6 Million
VALUATION Unknown
Rounds
Series A $12 Million
2020
Series B $64 Million
Series C $58 Million
Investors